Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.
You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!
If you have any problems with the registration process or your account login, please contact contact us.
Press Release: Ascension Orthopedics Receives FDA Approval For PyroCarbon Foot Implant
10 Jun 2006 - 0:00am (PDT)
Quote:
Ascension Orthopedics, Inc. announced today that it has received FDA approval on the first PyroCarbon implant for the foot. The Ascension(R) PyroSphere(R) implant is designed for the fourth and fifth tarsometatarsal joints of the foot and is intended for people suffering from the debilitating effects of arthritis in the foot.
"We are very pleased that the FDA has approved the PyroSphere(R) for the lower extremity. We are looking forward to providing the benefits of our implants to the foot and ankle surgeon," said Robert Martin, CEO of Ascension Orthopedics.
The Ascension(R) PyroSphere(R) is a revolution in TMT arthroplasty providing a new option to foot surgeons. The PyroSphere(R) is manufactured from the patented material, On-X(R) Carbon, which offers characteristics superior to those of other pyrocarbon material and is available only to Ascension Orthopedics. The material has shown improved wear qualities compared to other industry standard materials, thus enhancing the life of the implant.
The Ascension(R) PyroSphere(R) is the first PyroCarbon implant to be approved by the FDA in the lower extremity. This approval adds to the many firsts for Ascension Orthopedics in the extremity market.
"Our goal is to provide our customer, the extremity surgeon, with new and innovative solutions. Ascension will continue to lead the market in the development of small joint implants and innovation in extremity surgery," adds Robert Martin.
The company has expanded its product platforms to include arthroplasty, trauma, and tissue regeneration. Ascension currently offers more than ten arthroplasty products, a complete elbow trauma set, and a tissue regeneration portfolio that includes a nerve conduit and an adhesion prevention product. The entry into the foot market for Ascension marks its continued growth into the upper and lower extremity market.
FDA approval for PyroCarbon implant for midfoot osteoarthritis
Linear Mode
